Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Page 1
Post-transplant outcomes in recipients of living donor kidneys and intended recipients of living donor kidneys.
Dharia AA, Huang M, Nash MM, Dacouris N, Zaltzman JS, Prasad GVR. Dharia AA, et al. Among authors: zaltzman js. BMC Nephrol. 2022 Mar 5;23(1):97. doi: 10.1186/s12882-022-02718-6. BMC Nephrol. 2022. PMID: 35247959 Free PMC article.
BACKGROUND: Long-term kidney transplant survival at the population level is consistently favorable, but this survival varies widely at an individual level due to both recipient and donor factors. ...CONCLUSIONS: DD recipients with potential but non-actualized living donors …
BACKGROUND: Long-term kidney transplant survival at the population level is consistently favorable, but this survival varies widely a …
Commercial kidney transplantation is an important risk factor in long-term kidney allograft survival.
Prasad GVR, Ananth S, Palepu S, Huang M, Nash MM, Zaltzman JS. Prasad GVR, et al. Among authors: zaltzman js. Kidney Int. 2016 May;89(5):1119-1124. doi: 10.1016/j.kint.2015.12.047. Epub 2016 Mar 9. Kidney Int. 2016. PMID: 27083285 Free article.
Transplant tourism, a form of transplant commercialization, has resulted in serious short-term adverse outcomes that explain reduced short-term kidney allograft survival. However, the nature of longer-term outcomes in commercial kidney transplant recipients i …
Transplant tourism, a form of transplant commercialization, has resulted in serious short-term adverse outcomes that explain reduced …
Five-year study of tacrolimus as secondary intervention versus continuation of cyclosporine in renal transplant patients at risk for chronic renal allograft failure.
Jevnikar A, Arlen D, Barrett B, Boucher A, Cardella C, Cockfield SM, Rush D, Paraskevas S, Shapiro J, Shoker A, Yilmaz S, Zaltzman JS, Kiberd B. Jevnikar A, et al. Among authors: zaltzman js. Transplantation. 2008 Oct 15;86(7):953-60. doi: 10.1097/TP.0b013e318186dd0c. Transplantation. 2008. PMID: 18852662 Clinical Trial.
BACKGROUND: Chronic allograft nephropathy is the most frequent cause of long-term kidney allograft loss. Studies are desperately needed to improve long-term survival. ...This study tested the hypothesis that conversion from cyclosporine to tacrolimus might improve l …
BACKGROUND: Chronic allograft nephropathy is the most frequent cause of long-term kidney allograft loss. Studies are desperately need …
A comparison of the effects of C2-cyclosporine and C0-tacrolimus on renal function and cardiovascular risk factors in kidney transplant recipients.
Kim SJ, Prasad GV, Huang M, Nash MM, Famure O, Park J, Thenganatt MA, Chowdhury N, Cole EH, Fenton SS, Cattran DC, Zaltzman JS, Cardella CJ. Kim SJ, et al. Among authors: zaltzman js. Transplantation. 2006 Oct 15;82(7):924-30. doi: 10.1097/01.tp.0000239313.83735.33. Transplantation. 2006. PMID: 17038908
However, MAP, TC, and the risk of NODM were comparable in both treatment/monitoring groups. The long-term impact of short-term reductions in eGFR as a function of the type of treatment/monitoring strategy requires further study....
However, MAP, TC, and the risk of NODM were comparable in both treatment/monitoring groups. The long-term impact of short-term …